Prevention of Anxiety and Depression in Adolescent

Providing and implementing Clinical trial of the prevention package for anxiety and depression in adolescent

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201508274178N2

Enrollment

Registered

2016-12-07

Start date

2016-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Symptoms of anxiety. Condition 2: symptoms of Depression. Phobic anxiety disorders Depressive episode

Interventions

Intervention 1: Prevention package is performed in group format, in 8 sessions for experimental group. Intervention 2: Control group is waiting for intervention after performing the study.

Prevention

Prevention package is performed in group format, in 8 sessions for experimental group.

Control group is waiting for intervention after performing the study.

Eligibility

Sex/Gender

All

Age

11 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 11 to 18 years old; permission from parents of participants Exclusion criteria: having any cognitive or health problems that prevent students to participate to the program

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Symptoms of anxiety. Timepoint: before and after intervention and after 3 month fallow up. Method of measurement: Revised Children's Anxiety and Depression Scale (RCADS).;Symptoms of depression. Timepoint: before and after intervention and after 3 month fallow up. Method of measurement: Revised Children's Anxiety and Depression Scale (RCADS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Mohammadi

Tehran University of Medical Sciences

a-mohammadi@tums.ac.ir+98 21 5541 9151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026